digna Expands Data Analytics Capabilities with New Time-Series Analysis and Validation Features

April 15, 2026) - digna has announced Release 2026.04 of its data quality and observability platform, introducing new capabilities in time-series analytics and validation standardization designed to ...
ascopubs.org

Validation of a kinetic analysis of renal cancer regression and growth following treatment with sunitinib and interferon-alfa (IFN-α): Analysis of the pivotal randomized trial.

Patient preferences for targeted agents in renal cell carcinoma (RCC): A benefit–risk conjoint study. Background: We developed a novel method to analyze the response of tumors to therapy, quantifying ...
ascopubs.org

Regression Derived Staging Model to Predict Overall and Disease Specific Survival in Patients With Major Salivary Gland Carcinomas With Independent External Validation

The current American Joint Cancer Committee (AJCC) staging system for salivary gland tumors does not include histology and grade in its classification despite their proven prognostic importance. We ...